No black box warning on record for Clorazepate Dipotassium

As of the latest FDA labeling reviewed, Clorazepate Dipotassium (CLORAZEPATE DIPOTASSIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Clorazepate Dipotassium medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including clorazepate dipotassium, and opioids may result in profound sedation, respiratory depression, coma, and death. Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Observational studies have demonstrated that concomitant

No black box warning on record for Clorazepate Dipotassium

Other warnings & precautions

WARNINGS Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including clorazepate dipotassium, and opioids may result in profound sedation, respiratory depression, coma, and death. Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Observational studies have demonstrated that concomitant

Clorazepate Dipotassium Black Box Warning

No black box warning on record for Clorazepate Dipotassium

Other warnings & precautions

Clorazepate Dipotassium Black Box Warning

No black box warning on record for Clorazepate Dipotassium

Other warnings & precautions